Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark C. Schneyer currently holds 62,836 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark C. Schneyer has been a net seller of ACAD stock. They have purchased $0 and sold $2.2M worth of shares.
Mark C. Schneyer's most recent insider trade was on Apr 7, 2026, when they sold 2,709 shares at $22.20 per share.
Mark C. Schneyer serves as Executive at ACADIA PHARMACEUTICALS INC (ACAD). They have executed 47 insider transactions totaling $2.2M over their tenure at the company.
Mark C. Schneyer holds the position of Executive at ACADIA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Mark C. Schneyer has shown a selling trading pattern, with $0 in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark C. Schneyer was on Aug 18, 2025, when they sold $554.0K worth of ACAD shares. This transaction involved 22,000 shares at $25.18 per share.
Mark C. Schneyer currently owns 62,836 shares of ACADIA PHARMACEUTICALS INC (ACAD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark C. Schneyer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark C. Schneyer has 47 Form 4 filings on record as an insider at ACADIA PHARMACEUTICALS INC.
Set alerts for Mark C. Schneyer and 40,000+ other insiders.